25 related articles for article (PubMed ID: 16225630)
1. Injection Site Bullous Eruption and Generalized Rash Induced by Pegylated Interferon Treatment for Hepatitis C.
Toney RC; Agrawal RM; Loeffert M
Gastroenterol Hepatol (N Y); 2009 Oct; 5(10):715-718. PubMed ID: 37967399
[No Abstract] [Full Text] [Related]
2. Severe polymorphic erythema due to interferon α-2b during treatment of hairy cell leukemia.
Li C; Geng H; Ji L; Jiang Y; Ma X; Yin Q; Xiong H
J Int Med Res; 2019 Jul; 47(7):3453-3457. PubMed ID: 31248295
[TBL] [Abstract][Full Text] [Related]
3. A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin.
Mistry N; Shapero J; Crawford RI
Can J Gastroenterol; 2009 Oct; 23(10):677-83. PubMed ID: 19826642
[TBL] [Abstract][Full Text] [Related]
4. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection.
Girard C; Bessis D; Blatìre V; Guilhou JJ; Guillot B
Br J Dermatol; 2005 Jan; 152(1):182-3. PubMed ID: 15656829
[No Abstract] [Full Text] [Related]
5. Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment.
Vázquez-López F; Manjón-Haces JA; Pérez-Alvarez R; Pérez-Oliva N
Br J Dermatol; 2004 May; 150(5):1046-7; author reply 1047. PubMed ID: 15149535
[No Abstract] [Full Text] [Related]
6. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
[No Abstract] [Full Text] [Related]
7. Cutaneous reactions to interferon and ribavirin.
Chamberlain AJ; Poon E
Intern Med J; 2004 Aug; 34(8):519. PubMed ID: 15317557
[No Abstract] [Full Text] [Related]
8. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
Moore MM; Elpern DJ; Carter DJ
Arch Dermatol; 2004 Feb; 140(2):215-7. PubMed ID: 14967798
[TBL] [Abstract][Full Text] [Related]
9. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection.
Conde-Taboada A; de la Torre C; Feal C; Mayo E; Gonzalez-Sixto B; Cruces MJ
Br J Dermatol; 2005 Nov; 153(5):1070-2. PubMed ID: 16225630
[No Abstract] [Full Text] [Related]
10. Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C.
Wendling J; Descamps V; Grossin M; Marcellin P; Le Bozec P; Belaich S; Crickx B
Arch Dermatol; 2002 Apr; 138(4):546-7. PubMed ID: 11939833
[No Abstract] [Full Text] [Related]
11. Clinical and immunological features of hepatitis C treatment-associated dermatitis in 36 prospective cases.
Lübbe J; Kerl K; Negro F; Saurat JH
Br J Dermatol; 2005 Nov; 153(5):1088-90. PubMed ID: 16225644
[No Abstract] [Full Text] [Related]
12. Meyerson's phenomenon in a patient affected by high-risk melanoma under treatment with interferon-α.
Zonta E; Chiarion V; Zarian H; Peserico A; Alaibac M
Melanoma Res; 2012 Jun; 22(3):284-5. PubMed ID: 22543678
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
